Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.62 |
| ▸ | CALCR | P30988 | 7/20 | 0.58 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.58 |
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.56 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.56 |
| ▸ | APLNR | P35414 | 1/20 | 0.55 |
| ▸ | MC4R | P32245 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262180 | 0.91 | F2 (0.59) | C5AR1CALCRRAMP3F2NMUR2 | |
| SCHEMBL29588650 | 0.88 | MC4R (0.64) | CALCRRAMP3F2MC4R | |
| SCHEMBL29362632 | 0.88 | APLNR (0.61) | C5AR1CALCRRAMP3F2NMUR2 | |
| SCHEMBL29860218 | 0.87 | MC4R (0.64) | CALCRRAMP3F2MC4R | |
| SCHEMBL29903333 | 0.87 | APLNR (0.61) | C5AR1CALCRRAMP3F2NMUR2 | |
| SCHEMBL30432277 | 0.87 | CALCR (0.61) | CALCRRAMP3MC4R | |
| SCHEMBL29836372 | 0.86 | C5AR1 (0.63) | C5AR1CALCRRAMP3 | |
| SCHEMBL30906003 | 0.86 | C5AR1 (0.57) | C5AR1CALCRRAMP3APLNRMC4R | |
| SCHEMBL29679615 | 0.86 | RAMP3 (0.60) | C5AR1CALCRRAMP3F2NMUR2 | |
| SCHEMBL30906000 | 0.86 | C5AR1 (0.58) | C5AR1CALCRRAMP3APLNRMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |